Quality of Life, Aesthetic Result and Health Economy in Breast Reconstruction (GoBreast)

August 7, 2023 updated by: Vastra Gotaland Region

GoBreast - a Prospective Randomized Trial on Breast Reconstruction Methods

A randomized clinical trial with two arms: irradiated women and non-irradiated women. Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap. Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Irradiated patients:

Inclusion Criteria:

  • Age 18-60
  • DIEP is technically possible
  • Unilateral mastectomy
  • BMI<30

Exclusion Criteria:

  • Scars on abdomen or back
  • Bilateral mastectomy
  • Previous liposuction abdomen
  • 61 years of age or older

Non-irradiated patients

Inclusion Criteria:

->18 years of age

  • Unilateral mastectomy
  • BMI<30

Exclusion Criteria:

  • Bilateral mastectomy
  • extensive scars on thorax

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Irradiated women
Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap.
Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap. Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.
Other: Non-irradiated women
Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.
Irradiated women are randomized to reconstruction with a latissimus Dorsi flap and an implant or a deep inferior epigastria perforator flap. Non-irradiated women are randomized to reconstruction with a thoracodorsal flap with an implant or with an expander and later a permanent implant in two stages.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aesthetic outcome
Time Frame: 1 year post-operatively
Photo evaluations
1 year post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast related quality of life and satisfaction
Time Frame: Pre-operatively and 3 years post-operatively
Breast-q. Measures breast related quality of life on a scale 1-100. A higher score indicates a higher quality of life.
Pre-operatively and 3 years post-operatively
General quality of life measurement used for health economics
Time Frame: Pre-operatively and 3 years post-operatively
EuroQol-5 domensions-3 levels is a generic instrument developed for health economic and clinical evaluation of healthcare. A total score between 0 and 1 is calculated. Zero equals death and 1 perfect health.
Pre-operatively and 3 years post-operatively
Depression
Time Frame: Pre-operatively and 3 years post-operatively
Beck Depression Inventory (BDI 21) for mood assessment. Scale range is 0-63 and higher scores indicate worse outcome.
Pre-operatively and 3 years post-operatively
General quality of life
Time Frame: Pre-operatively and 3 years post-operatively
Short form health survey (SF-36). The scale ranges from 0 to 100 and a higher score indicates a better quality of life.
Pre-operatively and 3 years post-operatively
Early complication frequency
Time Frame: 2 weeks post-operatively
Complications described according to Clavien-Dindo
2 weeks post-operatively
Long-term complications
Time Frame: Five years post-operatively
Re-operations and corrections
Five years post-operatively
Health economics
Time Frame: Five years post-operatively
Costs of different procedures
Five years post-operatively
Implant survival
Time Frame: 19 years
Analysis of number of implants removed over time
19 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2008

Primary Completion (Actual)

April 1, 2020

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

May 21, 2019

First Submitted That Met QC Criteria

May 23, 2019

First Posted (Actual)

May 24, 2019

Study Record Updates

Last Update Posted (Actual)

August 8, 2023

Last Update Submitted That Met QC Criteria

August 7, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Bröst-07:2-4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery--Complications

Clinical Trials on Breast reconstruction

3
Subscribe